Teal Simon, Auger William R, Hughes Rodney J, Ramey Dena Rosen, Lewis Kelly S, O'Brien Gerald, Yaldo Avin, Burton Tanya M, Bancroft Tim, Seare Jerry, Fabian Joerg
1 Bayer AG, Berlin, Germany.
2 University of California, San Diego, LA Jolla, CA, USA.
Pulm Circ. 2019 Jan-Mar;9(1):2045894018814772. doi: 10.1177/2045894018814772. Epub 2018 Nov 13.
This study aimed to validate an algorithm developed to identify chronic thromboembolic pulmonary hypertension (CTEPH) among patients with a history of pulmonary embolism. Validation was halted because too few patients had gold-standard evidence of CTEPH in the administrative claims/electronic health records database, suggesting that CTEPH is underdiagnosed.
本研究旨在验证一种针对有肺栓塞病史的患者开发的用于识别慢性血栓栓塞性肺动脉高压(CTEPH)的算法。由于在管理性索赔/电子健康记录数据库中,仅有极少患者具备CTEPH的金标准证据,因此验证工作被迫中止,这表明CTEPH存在诊断不足的情况。